217 related articles for article (PubMed ID: 17628756)
1. Growth and body composition in children with classical phenylketonuria: results in 34 patients and review of the literature.
Huemer M; Huemer C; Möslinger D; Huter D; Stöckler-Ipsiroglu S
J Inherit Metab Dis; 2007 Oct; 30(5):694-9. PubMed ID: 17628756
[TBL] [Abstract][Full Text] [Related]
2. The relationship between dietary intake, growth and body composition in Phenylketonuria.
Evans M; Truby H; Boneh A
Mol Genet Metab; 2017 Sep; 122(1-2):36-42. PubMed ID: 28739202
[TBL] [Abstract][Full Text] [Related]
3. Whole body composition analysis by the BodPod air-displacement plethysmography method in children with phenylketonuria shows a higher body fat percentage.
Albersen M; Bonthuis M; de Roos NM; van den Hurk DA; Carbasius Weber E; Hendriks MM; de Sain-van der Velden MG; de Koning TJ; Visser G
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3(Suppl 3):S283-8. PubMed ID: 20574715
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria.
Dobbelaere D; Michaud L; Debrabander A; Vanderbecken S; Gottrand F; Turck D; Farriaux JP
J Inherit Metab Dis; 2003; 26(1):1-11. PubMed ID: 12872834
[TBL] [Abstract][Full Text] [Related]
5. Early dietary treated patients with phenylketonuria can achieve normal growth and body composition.
Rocha JC; van Spronsen FJ; Almeida MF; Ramos E; Guimarães JT; Borges N
Mol Genet Metab; 2013; 110 Suppl():S40-3. PubMed ID: 24183791
[TBL] [Abstract][Full Text] [Related]
6. Dietary intake and nutritional status of patients with phenylketonuria in Taiwan.
Weng HL; Yang FJ; Chen PR; Hwu WL; Lee NC; Chien YH
Sci Rep; 2020 Sep; 10(1):14537. PubMed ID: 32883979
[TBL] [Abstract][Full Text] [Related]
7. Phenylketonuric diet negatively impacts on butyrate production.
Verduci E; Moretti F; Bassanini G; Banderali G; Rovelli V; Casiraghi MC; Morace G; Borgo F; Borghi E
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):385-392. PubMed ID: 29502926
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of physical development in children with classical phenylketonuria].
Bushueva TV; Borovik TE; Ladodo KS; Kuzenkova LM; Maslova OI; Gevorkyan AK
Vopr Pitan; 2015; 84(2):34-43. PubMed ID: 26841554
[TBL] [Abstract][Full Text] [Related]
9. Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes.
Daly A; Högler W; Crabtree N; Shaw N; Evans S; Pinto A; Jackson R; Strauss BJ; Wilcox G; Rocha JC; Ashmore C; MacDonald A
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33923714
[TBL] [Abstract][Full Text] [Related]
10. Growth, Protein and Energy Intake in Children with PKU Taking a Weaning Protein Substitute in the First Two Years of Life: A Case-Control Study.
Evans S; Daly A; Wildgoose J; Cochrane B; Chahal S; Ashmore C; Loveridge N; MacDonald A
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30841589
[TBL] [Abstract][Full Text] [Related]
11. Over Restriction of Dietary Protein Allowance: The Importance of Ongoing Reassessment of Natural Protein Tolerance in Phenylketonuria.
Pinto A; Almeida MF; MacDonald A; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; Jackson R; van Spronsen F; Payne A; Rocha JC
Nutrients; 2019 Apr; 11(5):. PubMed ID: 31052331
[TBL] [Abstract][Full Text] [Related]
12. Physical development in patients with phenylketonuria on dietary treatment: a retrospective study.
Belanger-Quintana A; Martínez-Pardo M
Mol Genet Metab; 2011 Dec; 104(4):480-4. PubMed ID: 21878401
[TBL] [Abstract][Full Text] [Related]
13. Body protein in prepubertal children with phenylketonuria.
Allen JR; Baur LA; Waters DL; Humphries IR; Allen BJ; Roberts DC; Gaskin KJ
Eur J Clin Nutr; 1996 Mar; 50(3):178-86. PubMed ID: 8654332
[TBL] [Abstract][Full Text] [Related]
14. New insights in growth of phenylketonuric patients.
Couce ML; Guler I; Anca-Couce A; Lojo M; Mirás A; Leis R; Pérez-Muñuzuri A; Fraga JM; Gude F
Eur J Pediatr; 2015 May; 174(5):651-9. PubMed ID: 25367055
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density.
Lage S; Bueno M; Andrade F; Prieto JA; Delgado C; Legarda M; Sanjurjo P; Aldámiz-Echevarría LJ
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S363-71. PubMed ID: 20830525
[TBL] [Abstract][Full Text] [Related]
16. Carbohydrate status in patients with phenylketonuria.
Couce ML; Sánchez-Pintos P; Vitoria I; De Castro MJ; Aldámiz-Echevarría L; Correcher P; Fernández-Marmiesse A; Roca I; Hermida A; Martínez-Olmos M; Leis R
Orphanet J Rare Dis; 2018 Jun; 13(1):103. PubMed ID: 29945661
[TBL] [Abstract][Full Text] [Related]
17. The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria.
Daly A; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; MacDonald A
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32899700
[TBL] [Abstract][Full Text] [Related]
18. Physical growth in phenylketonuria: II. Growth of treated children in the PKU collaborative study from birth to 4 years of age.
Holm VA; Kronmal RA; Williamson M; Roche AF
Pediatrics; 1979 May; 63(5):700-7. PubMed ID: 312490
[TBL] [Abstract][Full Text] [Related]
19. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
[TBL] [Abstract][Full Text] [Related]
20. Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: impact on growth in PKU.
Aldámiz-Echevarría L; Bueno MA; Couce ML; Lage S; Dalmau J; Vitoria I; Andrade F; Llarena M; Blasco J; Alcalde C; Gil D; García MC; González-Lamuño D; Ruiz M; Ruiz MA; González D; Sánchez-Valverde F
Mol Genet Metab; 2013 Aug; 109(4):331-8. PubMed ID: 23810227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
